142 related articles for article (PubMed ID: 12826052)
1. Aberrant methylation of multiple genes in neuroblastic tumours. relationship with MYCN amplification and allelic status at 1p.
Gonzalez-Gomez P; Bello MJ; Lomas J; Arjona D; Alonso ME; Amiñoso C; Lopez-Marin I; Anselmo NP; Sarasa JL; Gutierrez M; Casartelli C; Rey JA
Eur J Cancer; 2003 Jul; 39(10):1478-85. PubMed ID: 12826052
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
[TBL] [Abstract][Full Text] [Related]
4. Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; De Campos JM; Kusak ME; Gutierrez M; Sarasa JL; Rey JA
Oncol Rep; 2003; 10(5):1519-23. PubMed ID: 12883734
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation status of multiple genes in brain metastases of solid tumors.
Gonzalez-Gomez P; Bello MJ; Alonso ME; Amiñoso C; Lopez-Marin I; De Campos JM; Isla A; Gutierrez M; Rey JA
Int J Mol Med; 2004 Jan; 13(1):93-8. PubMed ID: 14654977
[TBL] [Abstract][Full Text] [Related]
6. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.
Gumy-Pause F; Pardo B; Khoshbeen-Boudal M; Ansari M; Gayet-Ageron A; Sappino AP; Attiyeh EF; Ozsahin H
Genes Chromosomes Cancer; 2012 Feb; 51(2):174-85. PubMed ID: 22045684
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
8. Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas.
Muñoz J; Vendrell E; Aiza G; Nistal M; Pestaña A; Peinado MA; Castresana JS
Neuropathology; 2006 Jun; 26(3):165-9. PubMed ID: 16771170
[TBL] [Abstract][Full Text] [Related]
9. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.
Spitz R; Hero B; Skowron M; Ernestus K; Berthold F
Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958
[TBL] [Abstract][Full Text] [Related]
10. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.
Dong SM; Pang JC; Poon WS; Hu J; To KF; Chang AR; Ng HK
J Neuropathol Exp Neurol; 2001 Aug; 60(8):808-16. PubMed ID: 11487055
[TBL] [Abstract][Full Text] [Related]
11. Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome.
Iolascon A; Lo Cunsolo C; Giordani L; Cusano R; Mazzocco K; Boumgartner M; Ghisellini P; Faienza MF; Boni L; De Bernardi B; Conte M; Romeo G; Tonini GP
Cancer Lett; 1998 Aug; 130(1-2):83-92. PubMed ID: 9751260
[TBL] [Abstract][Full Text] [Related]
12. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas.
Alonso ME; Bello MJ; Gonzalez-Gomez P; Arjona D; Lomas J; de Campos JM; Isla A; Sarasa JL; Rey JA
Cancer Genet Cytogenet; 2003 Jul; 144(2):134-42. PubMed ID: 12850376
[TBL] [Abstract][Full Text] [Related]
14. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
15. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
16. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H
Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
[TBL] [Abstract][Full Text] [Related]
18. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
19. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.
Kramer K; Cheung NK; Gerald WL; LaQuaglia M; Kushner BH; LeClerc JM; LeSauter L; Saragovi HU
Eur J Cancer; 1997 Oct; 33(12):2098-100. PubMed ID: 9516861
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío IJ; Castresana JS
Cancer Genet Cytogenet; 2007 Apr; 174(1):1-8. PubMed ID: 17350460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
